Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate

被引:69
作者
Wu, Ting-Jung [1 ]
Lee, Li-Yu
Yeh, Chun-Nan
Wu, Pei-Yu
Chao, Tzu-Chieh
Hwang, Tsann-Long
Jan, Yi-Yin
Chen, Miin-Fu
机构
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Surg,Div Gen Surg, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan
关键词
D O I
10.1186/1471-230X-6-29
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Gastrointestinal stromal tumors (GISTs), the most common type of mesenchymal tumors of the gastrointestinal (GI) tract, demonstrate positive kit staining. We report our surgical experience with 100 small intestine GIST patients and identify predictors for long-term disease-free survival (DFS) and overall survival (OS) to clarify the difference between high- and low-risk patients. Methods: The clinicopathologic and follow-up records of 100 small intestine GIST patients who were treated at Chung Gung Memorial Hospital between 1983 and 2002 were retrospectively reviewed. Clinical and pathological factors were assessed for long-term DFS and OS by using a univariate log-rank test and a multivariate Cox proportional hazard model. Results: The patients included 52 men and 48 women. Their ages ranged from 27 to 82 years. Among the 85 patients who underwent curative resection, 44 (51.8%) developed disease recurrence (liver metastasis was the most common form of recurrence). The follow-up period ranged from 5 to 202 months ( median: 33.2 months). The 1-, 3-, and 5-year DFS and OS rates were 85.2%, 53.8%, and 43.7%, and 91.5%, 66.6%, and 50.5%, respectively. Using multivariate analysis, it was found that high tumor cellularity, mitotic count >5/50 high- power field, and a Ki-67 index >= 10% were three independent factors that were inversely associated with DFS. However, absence of tumor perforation, mitotic count < 5/50 high power field, and tumor with low cellularity were predictors of long-term favorable OS. Conclusion: Tumors with low cellularity, low mitotic count, and low Ki-67 index, which indicate low risk, predict a more favorable DFS for small intestine GIST patients undergoing curative resection. Absence of tumor perforation with low mitotic count and low cellularity, which indicates low risk, can predict long-term OS for small intestine GIST patients who have undergone curative resection.
引用
收藏
页数:8
相关论文
共 30 条
[1]  
AKWARI OE, 1978, CANCER, V42, P1375, DOI 10.1002/1097-0142(197809)42:3<1375::AID-CNCR2820420348>3.0.CO
[2]  
2-4
[3]   Stromal tumors of the jejunum and ileum - A clinicopathologic study of 39 cases [J].
Brainard, JA ;
Goldblum, JR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (04) :407-416
[4]   Small intestinal stromal tumors: A clinicopathologic study of 31 tumors [J].
Chang, MS ;
Choe, G ;
Kim, WH ;
Kim, YI .
PATHOLOGY INTERNATIONAL, 1998, 48 (05) :341-347
[5]   Smooth muscle tumors of the gastrointestinal tract: Analysis of prognostic factors [J].
Chou, FF ;
Eng, HL ;
SheenChen, SM .
SURGERY, 1996, 119 (02) :171-177
[6]   Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database [J].
Crosby, JA ;
Catton, CN ;
Davis, A ;
Couture, J ;
O'Sullivan, B ;
Kandel, R ;
Swallow, CJ .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (01) :50-59
[7]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[8]   SARCOMAS OF THE GASTROINTESTINAL-TRACT - SEPARATION INTO FAVORABLE AND UNFAVORABLE PROGNOSTIC GROUPS BY MITOTIC COUNT [J].
DOUGHERTY, MJ ;
COMPTON, C ;
TALBERT, M ;
WOOD, WC .
ANNALS OF SURGERY, 1991, 214 (05) :569-574
[9]   Prognosis of gastrointestinal smooth-muscle (Stromal) tumors - Dependence on anatomic site [J].
Emory, TS ;
Sobin, LH ;
Lukes, L ;
Lee, DH ;
O'Leary, TJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) :82-87
[10]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465